SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-13-106244
Filing Date
2013-03-14
Accepted
2013-03-14 08:41:12
Documents
14
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d444112d10k.htm 10-K 1137879
2 EX-10.19 d444112dex1019.htm EX-10.19 69696
3 EX-21.1 d444112dex211.htm EX-21.1 2023
4 EX-23.1 d444112dex231.htm EX-23.1 1856
5 EX-31.1 d444112dex311.htm EX-31.1 9155
6 EX-31.2 d444112dex312.htm EX-31.2 9192
7 EX-32.1 d444112dex321.htm EX-32.1 4697
14 GRAPHIC g444112g35q16.jpg GRAPHIC 68893
  Complete submission text file 0001193125-13-106244.txt   7430643

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT geva-20121231.xml EX-101.INS 1019436
9 XBRL TAXONOMY EXTENSION SCHEMA geva-20121231.xsd EX-101.SCH 67430
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE geva-20121231_cal.xml EX-101.CAL 76104
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE geva-20121231_def.xml EX-101.DEF 236893
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE geva-20121231_lab.xml EX-101.LAB 535971
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE geva-20121231_pre.xml EX-101.PRE 383805
Mailing Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421
Business Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421 (781) 357-9900
SYNAGEVA BIOPHARMA CORP (Filer) CIK: 0000911326 (see all company filings)

IRS No.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23155 | Film No.: 13689173
SIC: 2836 Biological Products, (No Diagnostic Substances)